quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:56:28·48d
SECFiling
Altimmune Inc. logo

SEC Form 10-K filed by Altimmune Inc.

ALT· Altimmune Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • ALT
    Altimmune Inc.
    Health Care

Recent analyst ratings

  • Mar 18UpdateTruist$12.00
  • Jan 28UpdateBarclays$20.00
  • Jul 10UpdateGoldman$1.00
  • Feb 28UpdateWilliam Blair-
  • Jan 8UpdateStifel$18.00
  • Nov 12UpdateUBS$26.00

Related

  • PR1d
    Altimmune Announces Pricing of $225 Million Oversubscribed Public Offering of Securities
  • SEC1d
    SEC Form S-3MEF filed by Altimmune Inc.
  • SEC1d
    SEC Form 424B5 filed by Altimmune Inc.
  • PR1d
    Altimmune Announces Proposed Underwritten Public Offering of Securities
  • SEC7d
    Altimmune Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
  • INSIDER17d
    SEC Form 4 filed by Gill John
  • INSIDER22d
    SEC Form 4 filed by Weaver Gregory L
  • INSIDER22d
    SEC Form 4 filed by Durso Jerome Benedict
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022